Track the latest Gain Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Gain Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Aug 12, 2024 | Gene Mack | CFO AND INTERIM CEO | 14.40K | $1.01 | $14.54K | BUY | ∞ | 14.40K | Aug 09 | View |
Aug 12, 2024 | Khalid Islam | EXECUTIVE CHAIRMAN | 50.00K | $1.00 | $49.94K | BUY | 5.68% | 930.78K | Aug 09 | View |
Jul 01, 2024 | Eric Richman | DIRECTOR | 17.00K | $1.22 | $20.67K | BUY | 5.91% | 304.46K | Jul 01 | View |
Apr 01, 2024 | Jeffrey Scott Riley | DIRECTOR | 30.00K | $3.86 | $115.77K | BUY | ∞ | 30.00K | Mar 28 | View |
Dec 22, 2023 | Matthias Alder | CHIEF EXECUTIVE OFFICER | 431.00 | $2.46 | -$506.76 | SELL-OPTIONS | 8.88% | 5.29K | Dec 20 - Dec 21 | View |
Dec 14, 2023 | Matthias Alder | CHIEF EXECUTIVE OFFICER | -1.82K | $2.50 | -$4.55K | SELL | -27.27% | 4.86K | Dec 07 | View |
May 27, 2022 | Eric I Richman | CHIEF EXECUTIVE OFFICER | 2.48K | $2.58 | $6.40K | BUY | 1.08% | 232.56K | May 25 | View |
May 23, 2022 | Eric I Richman | CHIEF EXECUTIVE OFFICER | 13.26K | $2.79 | $37.03K | BUY | 6.11% | 230.08K | May 19 - May 20 | View |
May 19, 2022 | Salvatore CAlabrese | CHIEF FINANCIAL OFFICER | 3.00K | $2.70 | $8.10K | BUY | ∞ | 0.00 | May 19 | View |
Browse insider trades on all stocks.